marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2025-Q2
added 08-13-2025
Aethlon Medical Operating Income 2011-2025 | AEMD
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.34 M | -12.6 M | -11.9 M | -10.4 M | -7.89 M | -5.93 M | -6 M | -4.83 M | -6.1 M | -4.38 M | -3.99 M | -3.06 M | -3.58 M | -3.11 M | -4.56 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.06 M | -12.6 M | -6.52 M |
Quarterly Operating Income Aethlon Medical
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.79 M | - | -1.81 M | -2.9 M | -2.62 M | - | -3.57 M | -3.18 M | -3.41 M | - | -2.85 M | -3.67 M | -2.91 M | - | -2.53 M | -6.64 M | -4.11 M | - | -2.44 M | -2.44 M | -1.77 M | -1.41 M | -876 K | -876 K | -1.7 M | -1.57 M | -1.96 M | -1.96 M | -1.35 M | - | -1.16 M | -1.24 M | -1.16 M | - | -1.24 M | -4.59 M | -3.36 M | - | -1.08 M | -3.3 M | -2.21 M | - | -1.09 M | -2.86 M | -1.77 M | - | -1.23 M | -2.25 M | -1.01 M | - | -937 K | -2.73 M | -1.79 M | - | -341 K | -2.26 M | -1.92 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -341 K | -6.64 M | -2.22 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Dynatronics Corporation
DYNT
|
-2.45 M | $ 0.24 | 14.99 % | $ 929 K |  USA |
 |
Aziyo Biologics
AZYO
|
-30.5 M | $ 1.48 | 1.37 % | $ 20.5 M | USA |
 |
Natus Medical Incorporated
NTUS
|
23.8 M | $ 31.08 | 1.94 % | $ 1.05 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | $ 20.0 | 0.15 % | $ 844 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | $ 30.03 | - | $ 111 M |  Canada |
 |
Apollo Endosurgery
APEN
|
-31.4 M | $ 10.0 | - | $ 475 M | USA |
 |
Titan Medical
TMDI
|
-31 M | $ 0.14 | -26.32 % | $ 19.6 M | Canada |
 |
Insulet Corporation
PODD
|
309 M | $ 320.45 | 2.38 % | $ 22.5 B | USA |
 |
Viveve Medical
VIVE
|
-21.6 M | $ 0.22 | -15.35 % | $ 1.71 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | $ 0.66 | - | $ 24.7 M | USA |
 |
Quanterix Corporation
QTRX
|
-49.7 M | $ 5.33 | -0.28 % | $ 200 M | USA |
 |
Abiomed
ABMD
|
230 M | $ 381.02 | - | $ 17.2 B | USA |
 |
AVITA Medical
RCEL
|
-56.6 M | $ 3.76 | -2.84 % | $ 97.3 M |  Australia |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | $ 0.55 | 3.58 % | $ 2.21 M | USA |
 |
Sintx Technologies
SINT
|
-13.4 M | $ 3.33 | 4.62 % | $ 12.4 M | USA |
 |
ShockWave Medical
SWAV
|
159 M | $ 334.75 | - | $ 12.3 B | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
-61 M | $ 7.16 | 0.28 % | $ 270 M | USA |
 |
ViewRay
VRAY
|
-107 M | $ 2.64 | 1.54 % | $ 468 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 38.83 | -0.3 % | $ 5.79 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | $ 70.98 | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | $ 0.13 | -13.19 % | $ 166 K | USA |
 |
Integer Holdings Corporation
ITGR
|
208 M | $ 66.39 | 2.87 % | $ 2.23 B | USA |
 |
Eargo
EAR
|
-112 M | $ 2.57 | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
-12.4 M | $ 9.5 | -3.36 % | $ 271 M | USA |
 |
Viemed Healthcare
VMD
|
14.3 M | $ 6.55 | 1.39 % | $ 251 M | USA |
 |
SmileDirectClub
SDC
|
-262 M | $ 0.08 | -53.45 % | $ 9.71 M | USA |
 |
Globus Medical
GMED
|
166 M | $ 60.86 | 0.78 % | $ 8.26 B | USA |
 |
ThermoGenesis Holdings
THMO
|
-6.19 M | $ 0.31 | -25.84 % | $ 171 K | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | $ 0.09 | -26.83 % | $ 2.62 M | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 19.02 | -18.07 % | $ 514 M | USA |
 |
Surgalign Holdings
SRGA
|
-78.5 M | $ 0.18 | -32.98 % | $ 1.68 M | USA |
 |
Conformis
CFMS
|
-46.3 M | $ 2.27 | - | $ 16.4 M | USA |
 |
Sientra
SIEN
|
-46.4 M | $ 0.18 | -16.59 % | $ 10.3 M | USA |
 |
Cutera
CUTR
|
-156 M | $ 0.1 | -10.19 % | $ 1.99 M | USA |
 |
Nemaura Medical
NMRD
|
-9.6 M | $ 0.11 | -17.8 % | $ 2.74 M |  Britain |
 |
Vapotherm
VAPO
|
-39.1 M | $ 1.27 | 6.72 % | $ 34 M | USA |
 |
Beyond Air
XAIR
|
-44.5 M | $ 1.94 | -5.83 % | $ 131 M | USA |
 |
Xtant Medical Holdings
XTNT
|
-12.1 M | $ 0.82 | -6.71 % | $ 110 M | USA |
 |
Pulmonx Corporation
LUNG
|
-57.7 M | $ 1.81 | -9.5 % | $ 70.8 M | USA |